Up-regulation of miR-132 through the TGF-β1/Smad2/3 signaling pathway is of benefit to delay the progression of PF and the therapeutic approach aimed at upregulated miR-132 deserves attention as a potential treatment for PF. Here, SMAD2 is linked to pemphigus foliaceus.